Wockhardt Raises ₹480 Crore to Accelerate Antibiotic Trials and Debt Reduction
In a strategic move to propel its drug development initiatives and alleviate debt burdens, pharmaceutical giant Wockhardt has successfully raised […]
Wockhardt Hospitals: Ensuring Fast & Easy Access to Healthcare Services
Wockhardt Hospitals has been not only adopting latest technologies, but also establishing an environment allowing experimentation and customisation according to […]
Cipla and Wockhardt jointly to tackle antimicrobial resistance
Major Indian drug makers Cipla and Wockhardt are among a group of 13 global pharmaceutical firms which have come together […]
Latest Tech KID on the Roads
By serving in emergency situations with great deal of efficiency, the MMUs mark the beginning of a new age of technology […]
HealthSprint Networks
P RAMMOHAN Managing Director COMPANY NAME: HEATLHSPRINT NETWORKS PVT LTD Corporate Headquarters No 21, 3rd Floor, 6th Cross, Intermediate Ring […]
Annual special Issue 2008: January 2008 Issue
EDITORIAL Its yet another new year …and a new beginning indeed ! Enhancing the Usability of EMR through multimodal interactions […]
Wockhardt
Pharmaceutical and Biotechnology major Wockhardt Limited today announced its first quarter results (April
Wockhardt
Pharmaceutical and Biotechnology major Wockhardt Limited today announced its results for the FY 2010-11 (April 2010
Wockhardt in Debt
The FCCB holders, funded by QVT, Sun Pharma and Syndicate Bank, hold bonds worth $42 million in a pharmaceutical company Wockhardt Ltd.
Indian Drugmakers To Earn Good In US Market
Indian drug makers are now tapping their feet to become the world
Wockhardt jumps on US FDA nod for generic drug
Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
Wockhardt settles Entacapone patent and license agreement with Orion Corporation
Wockhardt Limited have uted the Entacapone patent settlement and license agreement with Orion Corporation in US.
Wockhardt registers healthy growth in sales, operating margins and new acquisitions in ’08, but drags over MTM losses
Wockhardt Limited recently announced its financial results for ’08.
